Bortezomib: a new player in pre- and post-transplant desensitization?

Bortezomib as the Sole Post-Renal Transplantation Desensitization Agent Does Not Decrease Donor-Specific Anti-HLA Antibodies

(2010) R. Sberro-Soussan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Identification of known drugs that act as inhibitors of NF-κB signaling and their mechanism of action

(2010) Susanne C. Miller et al.   BIOCHEMICAL PHARMACOLOGY

Successful treatment of IgM-mediated autoimmune hemolytic anemia with bortezomib

(2010) K. R. Carson et al.   BLOOD

Immunoproteasome beta subunit 10 is increased in chronic antibody-mediated rejection

(2010) Joanna Ashton-Chess et al.   KIDNEY INTERNATIONAL

Effect of the Proteasome Inhibitor Bortezomib on Humoral Immunity in Two Presensitized Renal Transplant Candidates

(2010) Markus Wahrmann et al.   TRANSPLANTATION

Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

(2010) R Carlin Walsh et al.   TRANSPLANTATION

Mechanisms of Alloantibody Production in Sensitized Renal Allograft Recipients

(2009) M. D. Stegall et al.   AMERICAN JOURNAL OF TRANSPLANTATION

De NovoDonor-Specific Antibody at the Time of Kidney Transplant Biopsy Associates with Microvascular Pathology and Late Graft Failure

(2009) L. G. Hidalgo et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Reducing De Novo Donor-Specific Antibody Levels during Acute Rejection Diminishes Renal Allograft Loss

(2009) M. J. Everly et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Outcome of Subclinical Antibody-Mediated Rejection in Kidney Transplant Recipients with Preformed Donor-Specific Antibodies

(2009) A. Loupy et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A Review

(2009) John Koreth et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Bortezomib, Dexamethasone, and Fibroblast Growth Factor Receptor 3-Specific Tyrosine Kinase Inhibitor in t(4;14) Myeloma

(2009) G. Bisping et al.   CLINICAL CANCER RESEARCH

Infections in Patients with Multiple Myeloma in the Era of High‐Dose Therapy and Novel Agents

(2009) Marcio Nucci et al.   CLINICAL INFECTIOUS DISEASES

Novel B Cell Therapeutic Targets in Transplantation and Immune-Mediated Glomerular Diseases

(2009) F. Vincenti et al.   Clinical Journal of the American Society of Nephrology

Proteasome Inhibitors in Cancer Therapy

(2009) Ugo Testa   CURRENT DRUG TARGETS

Management of the highly sensitized patient

(2009) Frans HJ Claas et al.   CURRENT OPINION IN IMMUNOLOGY

Bortezomib

(2009) Monique P. Curran et al.   DRUGS

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

(2009) B. Blanco et al.   HAEMATOLOGICA

Proteasome inhibition activates the mitochondrial pathway of apoptosis in human CD4+T cells

(2009) Carsten Berges et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Proteasome inhibitors in the treatment of multiple myeloma

(2009) J J Shah et al.   LEUKEMIA

Bortezomib Can Suppress Activation of Rapamycin-Resistant Memory T Cells Without Affecting Regulatory T-Cell Viability in Non-Human Primates

(2009) Jung-Sik Kim et al.   TRANSPLANTATION

Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts

(2009) Nils Lachmann et al.   TRANSPLANTATION

Enhanced Kidney Allocation to Highly Sensitized Patients by the Acceptable Mismatch Program

(2009) Frans H. J. Claas et al.   TRANSPLANTATION

Restorative and Rejection-Associated Lymphangiogenesis After Renal Transplantation: Friend or Foe?

(2009) David G. Vass et al.   TRANSPLANTATION

Abrogation of Anti-HLA Antibodies via Proteasome Inhibition

(2009) Hargovind L. Trivedi et al.   TRANSPLANTATION

HLA-Specific Antibodies Developed in the First Year Posttransplant are Predictive of Chronic Rejection and Renal Graft Loss

(2009) Po-Chang Lee et al.   TRANSPLANTATION

Acute Humoral Rejection in a Lung Recipient: Reversion With Bortezomib

(2009) Jorge Neumann et al.   TRANSPLANTATION

Alloantibody Levels and Acute Humoral Rejection Early After Positive Crossmatch Kidney Transplantation

(2008) J. M. Burns et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Transplant Glomerulopathy

(2008) F. G. Cosio et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Proteasome Inhibition Causes Apoptosis of Normal Human Plasma Cells Preventing Alloantibody Production

(2008) D. K. Perry et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The proteasome inhibitor bortezomib depletes plasma cells and protects mice with lupus-like disease from nephritis

(2008) Kirsten Neubert et al.   NATURE MEDICINE

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

(2008) Ashley A. Vo et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

(2008) Jesús F. San Miguel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bortezomib Provides Effective Therapy for Antibody- and Cell-Mediated Acute Rejection

(2008) Matthew J. Everly et al.   TRANSPLANTATION